Skip to main content
Fig. 1 | BMC Cancer

Fig. 1

From: NDRG2 mRNA levels and miR-28-5p and miR-650 activity in chronic lymphocytic leukemia

Fig. 1

a Determination of NDRG2 mRNA expression in the102 CLL patients and 40 normal B-cell samples by RT-PCR. ***P < 0.001. b Dot-plot of NDRG2 mRNA expression in CLL patients. Significant associations were found with Binet stage B/C vs. A, high LDH level vs. normal LDH level, IGHV un-mutated vs. IGHV mutated and p53 aberrations vs. no p53 aberrations. ***P < 0.001, **P < 0.01, *P < 0.05. c Time to treatment (TTT) curve of CLL based on NDRG2 mRNA by Kaplan-Meier estimation. d Overall survival (OS) curve of CLL based on NDRG2 mRNA by Kaplan-Meier estimation

Back to article page